Dexmedetomidine use in the ICU: Are we there yet?

Critical Care

Volumn 17, Issue 3, 2013, Pages

  Ahmed, Shakeel ^a   Murugan, Raghavan ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXMEDETOMIDINE; MIDAZOLAM; PROPOFOL; HYPNOTIC SEDATIVE AGENT;

ARTICLE; ARTIFICIAL VENTILATION; BRADYCARDIA; DRUG EFFICACY; EXTUBATION; HOSPITALIZATION; HUMAN; HYPOTENSION; INTENSIVE CARE UNIT; INTERPERSONAL COMMUNICATION; LENGTH OF STAY; MORTALITY; MULTICENTER STUDY (TOPIC); PAIN; PAIN ASSESSMENT; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEDATION; TREATMENT DURATION; VISUAL ANALOG SCALE; CONSCIOUS SEDATION; FEMALE; MALE; PROCEDURES;

COMMUNICATION; CONSCIOUS SEDATION; DEXMEDETOMIDINE; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDAZOLAM; PROPOFOL; RESPIRATION, ARTIFICIAL;

EID: 84878536222     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc12707     Document Type: Article

References (16)

1. Sydow M, Neumann P. Sedation for the critically ill. Intensive Care Med 1999, 25:634-636. 10.1007/s001340050917, 10416920.
2. Nasraway SA, Jacobi J, Murray MJ, Lumb PD, Task Force of the American College of Critical Care Medicine of the Society of Critical Care Medicine and the American society of health-System Pharmacists, American College of Chest Physicians Sedation, analgesia, and neuromuscular blockade of the critically ill adult: revised clinical practice guidelines for 2002. Crit Care Med 2002, 30:117-118. 10.1097/00003246-200201000-00019, 11902252, Task Force of the American College of Critical Care Medicine of the Society of Critical Care Medicine and the American society of health-System Pharmacists, American College of Chest Physicians.
3. Kollef MH, Levy NT, Ahrens TS, Schaiff R, Prentice D, Sherman G. The use of continuous i.v. sedation is associated with prolongation of mechanical ventilation. Chest 1998, 114:541-548. 10.1378/chest.114.2.541, 9726743.
4. Kress JP, Pohlman AS, O'Connor MF, Hall JB. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 2000, 342:1471-1477. 10.1056/NEJM200005183422002, 10816184.
5. Brook AD, Ahrens TS, Schaiff R, Prentice D, Sherman G, Shannon W, Kollef MH. Effect of a nursing implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med 1999, 27:2609-2615. 10.1097/00003246-199912000-00001, 10628598.
6. Girard TD, Kress JP, Fuchs BD, Thomason JW, Schweickert WD, Pun BT, Taichman DB, Dunn JG, Pohlman AS, Kinniry PA, Jackson JC, Canonico AE, Light RW, Shintani AK, Thompson JL, Gordon SM, Hall JB, Dittus RS, Bernard GR, Ely EW. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomized controlled trial. Lancet 2008, 371:126-134. 10.1016/S0140-6736(08)60105-1, 18191684.
7. Jones C, Bäckman C, Capuzzo M, Flaatten H, Rylander C, Griffiths RD. Precipitants of post-traumatic stress disorder following intensive care: a hypothesis generating study of diversity in Care. Intensive Care Med 2007, 33:978-985. 10.1007/s00134-007-0600-8, 17384929.
8. Mehta S, Burry L, Cook D, Fergusson D, Steinberg M, Granton J, Herridge M, Ferguson N, Devlin J, Tanios M, Dodek P, Fowler R, Burns K, Jacka M, Olafson K, Skrobik Y, Hébert P, Sabri E, Meade M, SLEAP Investigators; Canadian Critical Care Trials Group Daily sedation interruption in mechanically ventilated critically ill patients cared for with a sedation protocol: a randomized controlled trial. JAMA 2012, 308:1985-1992. Erratum in JAMA 2013, 309:237, 10.1001/jama.2012.13872, 23180503, SLEAP Investigators; Canadian Critical Care Trials Group.
9. Swart EL, Zuideveld KP, de Jongh J, Danhof M, Thijs LG, Strack van Schijndel RM. Population pharmacodynamic modelling of lorazepam- and midazolam-induced sedation upon long-term continuous infusion in critically ill patients. Eur J Clin Pharmacology 2006, 62:185-194. 10.1007/s00228-005-0085-8, 16425056.
10. Barr J, Egan TD, Sandoval NF, Zomorodi K, Cohane C, Gambus PL, Shafer SL. Propofol dosing regimens for ICU sedation based upon an integrated pharmacokinetic-pharmacodynamic model. Anesthesiology 2001, 95:324-333. 10.1097/00000542-200108000-00011, 11506101.
11. Barr J, Fraser GL, Puntillo K, Ely EW, Gélinas C, Dasta JF, Davidson JE, Devlin JW, Kress JP, Joffe AM, Coursin DB, Herr DL, Tung A, Robinson BR, Fontaine DK, Ramsay MA, Riker RR, Sessler CN, Pun B, Skrobik Y, Jaeschke R, American College of Critical Care Medicine Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med 2013, 41:263-306. American College of Critical Care Medicine.
12. Roberts RJ, Barletta JF, Fong JJ, Schumaker G, Kuper PJ, Papadopoulos S, Yogaratnam D, Kendall E, Xamplas R, Gerlach AT, Szumita PM, Anger KE, Arpino PA, Voils SA, Grgurich P, Ruthazer R, Devlin JW. Incidence of propofolrelated infusion syndrome in critically ill adults: a prospective, multicenter study. Crit Care 2009, 13:R169. 10.1186/cc8145, 2784401, 19874582.
13. Bhana N, Goa KL, McClellan KJ. Dexmedetomidine. Drugs 2000, 59:263-268. Discussion 269-270, 10.2165/00003495-200059020-00012, 10730549.
14. Ruokonen E, Parviainen I, Jakob SM, Nunes S, Kaukonen M, Shepherd ST, Sarapohja T, Bratty JR, Takala J, "Dexmedetomidine for Continuous Sedation" Investigators Dexmedetomidine versus propofol/midazolam for long-term sedation during mechanical ventilation. Intensive Care Med 2009, 35:282-290. 10.1007/s00134-008-1296-0, 18795253, "Dexmedetomidine for Continuous Sedation" Investigators.
15. Riker RR, Shehabi Y, Bokesch PM, Ceraso D, Wisemandle W, Koura F, Whitten P, Margolis BD, Byrne DW, Ely EW, Rocha MG, SEDCOM (Safety and Efficacy of Dexmedetomidine Compared With Midazolam) Study Group Dexmedetomidine vs. midazolam for sedation of critically ill patients: a randomized trial. JAMA 2009, 301:489-499. 10.1001/jama.2009.56, 19188334, SEDCOM (Safety and Efficacy of Dexmedetomidine Compared With Midazolam) Study Group.
16. Pandharipande PP, Pun BT, Herr DL, Maze M, Girard TD, Miller RR, Shintani AK, Thompson JL, Jackson JC, Deppen SA, Stiles RA, Dittus RS, Bernard GR, Ely EW. Effect of sedation with dexmedetomidine vs. lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA 2007, 298:2644-2653. 10.1001/jama.298.22.2644, 18073360.